{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:34:47Z","timestamp":1787070887037,"version":"build-2736575974"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Suppl 2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:title>ABSTRACTS<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>Central nervous system (CNS) metastasis originating from gynecological cancer is a very rare and late manifestation of the disease. Therefore, there is still limited data on prognostic factors for survival. The objective of the present study is to identify prognostic factors for survival in patients with CNS metastasis originating from gynecological cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study Design:<\/jats:title>\n                    <jats:p>The present retrospective study analyzed the patients with gynecological cancers who were treated due to CNS metastases between January 1999 and December 2019 at Istanbul University Hospital.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Forty-seven patients with CNS metastasis of gynecological origin were included in the study. The median age at the time of CNS metastasis was 59 (range 34\u201393). The median time from initial cancer diagnosis to CNS metastasis was 24.9 (range: 0\u2013108.2) months. Most patients had epithelial ovarian cancer (EOC) (76.6%), followed by endometrial cancer (EC) (14.8%), cervical cancer (CC) (4.3%), and vulvar cancer (VC) (4.3%). By multivariate analysis, the presence of extracranial metastasis (HR: 5.10; 95% CI: 1.71-15.18), Eastern Cooperative Oncology Group (ECOG) performance status \u22653 (HR: 2.92; 95% CI: 1.36-6.26), palliative care only for the treatment of CNS metastasis (HR: 1.47; 95% CI: 0.58-4.11), and treatment-free interval (TFI) &lt;6 months (HR: 2.74; 95% CI: 1.23-6.08) were independent factors that associated with worse survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Patients with CNS metastasis who have favorable prognostic factors are considered to be appropriate candidates for aggressive and long-term treatment strategies. Extracranial metastasis, ECOG performance status, treatment history of CNS metastasis, and TFI were determined as independent prognostic factors that improved survival. TFI might be taken into account as a prognostic factor for patients with CNS metastasis in gynecological cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_499_22","type":"journal-article","created":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T03:01:30Z","timestamp":1708484490000},"page":"S523-S529","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Central nervous system metastasis in gynecologic cancers: Seeking the prognostic factors"],"prefix":"10.4103","volume":"19","author":[{"given":"Yagmur","family":"Minareci","sequence":"first","affiliation":[{"name":"Department of Gynecologic Oncology, Eskisehir City Hospital, Eskisehir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naziye","family":"Ak","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology Istanbul University, Institute of Oncology, Istanbul University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozgur Ayd\u0131n","family":"Tosun","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Division of Gynecologic Oncology Istanbul Medeniyet University, Goztepe Research and Training Hospital, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamdullah","family":"Sozen","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Division of Gynecologic Oncology, Faculty of Medicine, Istanbul University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinar Mualla","family":"Saip","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology Istanbul University, Institute of Oncology, Istanbul University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samet","family":"Topuz","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Division of Gynecologic Oncology, Faculty of Medicine, Istanbul University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Yavuz","family":"Salihoglu","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Division of Gynecologic Oncology, Faculty of Medicine, Istanbul University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,4,27]]},"reference":[{"key":"R1-20241021","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1002\/cncr.10541","article-title":"Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma","volume":"94","author":"Schouten","year":"2002","journal-title":"Cancer"},{"key":"R2-20241021","first-page":"527453","article-title":"Brain metastases from ovarian carcinoma","author":"Piura","year":"2011","journal-title":"ISRN Oncol 2011"},{"key":"R3-20241021","first-page":"581749","article-title":"Brain metastases from endometrial carcinoma","author":"Piura","year":"2012","journal-title":"ISRN Oncol 2012"},{"key":"R4-20241021","first-page":"567","article-title":"Brain metastases from cervical carcinoma: Overview of pertinent literature","volume":"33","author":"Piura","year":"2012","journal-title":"Eur J Gynaecol Oncol"},{"key":"R5-20241021","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2176\/nmc.48.57","article-title":"Treatment and prognosis of brain metastases from gynecological cancers","volume":"48","author":"Ogawa","year":"2008","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"R6-20241021","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.2147\/TCRM.S200813","article-title":"Gamma knife radiosurgery for brain vascular malformations: Current evidence and future tasks","volume":"15","author":"Hasegawa","year":"2019","journal-title":"Ther Clin Risk Manag"},{"key":"R7-20241021","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1001\/archneur.1978.00500350058012","article-title":"Treatment for patients with cerebral metastases","volume":"35","author":"Markesbery","year":"1978","journal-title":"Arch Neurol"},{"key":"R8-20241021","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ijrobp.2020.01.051","article-title":"Beyond an updated graded prognostic assessment (Breast GPA): A prognostic index and trends in treatment and survival in breast cancer brain metastases from 1985 to today","volume":"107","author":"Sperduto","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R9-20241021","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1200\/JCO.2011.38.0527","article-title":"Summary report on the graded prognostic assessment: An accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases","volume":"30","author":"Sperduto","year":"2012","journal-title":"J Clin Oncol"},{"key":"R10-20241021","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF02782192","article-title":"Long-term survival with metastatic cancer to the brain","volume":"17","author":"Hall","year":"2000","journal-title":"Med Oncol"},{"key":"R11-20241021","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0360-3016(96)00619-0","article-title":"Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials","volume":"37","author":"Gaspar","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R12-20241021","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ijrobp.2009.08.025","article-title":"Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: A multi-institutional analysis of 4,259 patients","volume":"77","author":"Sperduto","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R13-20241021","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.radonc.2013.01.015","article-title":"The clinical utility of prognostic scoring systems in patients with brain metastases treated with radiosurgery","volume":"106","author":"Zindler","year":"2013","journal-title":"Radiother Oncol"},{"issue":"6 Suppl","key":"R14-20241021","doi-asserted-by":"crossref","first-page":"91S","DOI":"10.1111\/1523-1747.ep12876046","article-title":"The biology of the T-cell antigen receptor and its role in the skin immune system","volume":"94","author":"Siu","year":"1990","journal-title":"J Invest Dermatol"},{"key":"R15-20241021","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.3390\/cancers12082156","article-title":"Brain metastases from ovarian cancer: Current evidence in diagnosis, treatment, and prognosis","volume":"12","author":"Borella","year":"2020","journal-title":"Cancers (Basel)"},{"key":"R16-20241021","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ygyno.2012.11.001","article-title":"Clinicopathologic features of brain metastases from gynecologic malignancies: A retrospective study of 139 cases (KCOG-G1001s trial)","volume":"128","author":"Nasu","year":"2013","journal-title":"Gynecol Oncol"},{"key":"R17-20241021","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/jjco\/hyx047","article-title":"Prognostic factors for patients with brain metastasis from gynecological cancer: A significance of treatment-free interval of more than 6 months","volume":"47","author":"Takeshita","year":"2017","journal-title":"Jpn J Clin Oncol"},{"key":"R18-20241021","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.ygyno.2016.09.025","article-title":"Brain metastases in patients with EOC: Clinico-pathological and prognostic factors. A multicentric retrospective analysis from the MITO group (MITO 19)","volume":"143","author":"Marchetti","year":"2016","journal-title":"Gynecol Oncol"},{"key":"R19-20241021","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ygyno.2014.12.020","article-title":"Central nervous system metastasis in gynecologic cancer: Symptom management, prognosis and palliative management strategies","volume":"136","author":"Walter","year":"2015","journal-title":"Gynecol Oncol"},{"key":"R20-20241021","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ygyno.2009.05.030","article-title":"Prognostic factors for survival and intracerebral control after irradiation for brain metastases from gynecological cancer","volume":"114","author":"Rades","year":"2009","journal-title":"Gynecol Oncol"},{"key":"R21-20241021","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1097\/IGC.0000000000000554","article-title":"Factors predictive of improved survival in patients with brain metastases from gynecologic cancer: A single institution retrospective study of 47 cases and review of the literature","volume":"25","author":"Gressel","year":"2015","journal-title":"Int J Gynecol Cancer"},{"key":"R22-20241021","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000494334","article-title":"Survival impact of optimal surgical cytoreduction in recurrent epithelial ovarian cancer with brain metastasis","volume":"42","author":"Keskin","year":"2019","journal-title":"Oncol Res Treat"},{"key":"R23-20241021","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1525-1438.2007.01011.x","article-title":"Extent of extracranial disease is a powerful predictor of survival in patients with brain metastases from gynecological cancer","volume":"18","author":"Growdon","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"R24-20241021","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3346\/jkms.2015.30.1.66","article-title":"A clinical analysis of brain metastasis in gynecologic cancer: A retrospective multi-institute analysis","volume":"30","author":"Kim","year":"2015","journal-title":"J Korean Med Sci"},{"key":"R25-20241021","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1006\/gyno.2002.6653","article-title":"Evaluation of prognostic factors and treatment modalities in ovarian cancer patients with brain metastases","volume":"85","author":"Anupol","year":"2002","journal-title":"Gynecol Oncol"},{"key":"R26-20241021","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1006\/gyno.1995.1134","article-title":"Brain metastases in epithelial ovarian carcinoma","volume":"57","author":"Geisler","year":"1995","journal-title":"Gynecol Oncol"},{"key":"R27-20241021","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0090-8258(03)00060-X","article-title":"Surgical resection of solitary brain metastasis from ovarian carcinoma: An analysis of 22 cases","volume":"89","author":"Cormio","year":"2003","journal-title":"Gynecol Oncol"},{"key":"R28-20241021","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1006\/gyno.1997.4642","article-title":"Successful treatment of brain metastases from ovarian cancer using gamma-knife radiosurgery","volume":"65","author":"Kawana","year":"1997","journal-title":"Gynecol Oncol"},{"key":"R29-20241021","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/jnci\/87.1.34","article-title":"Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases","volume":"87","author":"Alexander","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"R30-20241021","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1447-0756.2010.01219.x","article-title":"Brain metastasis from uterine cervical cancer","volume":"36","author":"Park","year":"2010","journal-title":"J Obstet Gynaecol Res"},{"key":"R31-20241021","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S1701-2163(15)30838-0","article-title":"Brain metastases in women with epithelial ovarian cancer: Multimodal treatment including surgery or gamma-knife radiation is associated with prolonged survival","volume":"35","author":"Niu","year":"2013","journal-title":"J Obstet Gynaecol Can"},{"key":"R32-20241021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-014-1447-9","article-title":"Brain metastasis from ovarian cancer: A systematic review","volume":"119","author":"Pakneshan","year":"2014","journal-title":"J Neurooncol"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_499_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:38:16Z","timestamp":1787067496000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_499_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":32,"journal-issue":{"issue":"Suppl 2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_499_22","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"2022-02-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}